Company: SUPN
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001104659-25-042531
Chunk: 38

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 38
---
 year-end analysis of competitive market data and our annual review of Corporate Objectives and individual performance. Base Salaries Base salaries are paid in order to provide a fixed component of compensation for the CEO, CFO, other NEOs and other members of executive management. For 2024, on February 22, 2024, the Compensation Committee, based its assessment of performance, the CEO’s recommendation and comparison with data from the Aon report, reviewed the base salaries of the CEO and the CFO, other NEOs and the other executive officers. Each executive officer’s individual performance and tenure were also evaluated. For each of these executive officers, based on the CEO’s recommendation (other than with respect to the CEO) and the executive officer’s individual performance and contribution to the achievement of Corporate Objectives, the Compensation Committee approved an increase in the respective base salary from the 2024 level (other than with respect to the CEO) to be within a range that is competitive with salaries paid to comparable officers at companies in the Peer Group. With respect to the CEO, based on the foregoing, the Compensation Committee recommended the Board of Directors approve an increase of the CEO’s base salary from the 2023 level to be within a range that is competitive with salaries paid to comparable CEOs at companies in the Peer Group. The full Board of Directors reviewed the approved increase and approved an increase in the CEO’s base salary based on its review and the Compensation Committee’s recommendation. The table below sets forth our NEOs base salaries for 2023 and 2024.

| ​                         
 Name                      | ​ 
 ​ | ​ 
 ​ | Base Salary 
 2023        |   |         |   | ​ | ​ | 2024 |   |           |   | ​ 
 ​ | ​ | PercentageChange |   |      |   | ​ |
|:--------------------------|:--|:--|:------------|:--|--------:|:--|:--|:--|:-----|:--|----------:|:--|:--|:--|:-----------------|:--|:-----|:--|:--|
| Jack A. Khattar           | ​ | ​ | ​           | $ | 963,000 | ​ | ​ | ​ | ​    | $ | 1,001,500 | ​ | ​ | ​ | ​                | ​ | 4.0% | ​ | ​ |
| Timothy C. Dec            | ​ | ​ | ​           | $ |